رادار التجارب السريرية

رادار التجارب AI مرشح للتجارب أو مريض مقدم رعاية المريض محترف الرعاية الصحية محترف التكنولوجيا الحيوية مستثمر في التكنولوجيا الحيوية باحث أخرى
	يتم الآن عرض التجارب السريرية الخاصة بـ سرطان عنق الرحم المتكرر. يمكنني مساعدتك على العثور على التجارب السريرية في مواقع محددة وتقديم رؤى طبية متقدمة حول الحالات الصحية والعلاجات. مع الوضع المتقدم، يمكنك الوصول إلى أدوات الفرز المسبق القوية، وتصورات بيانية تفاعلية، وتنبيهات بريد إلكتروني مخصصة لتحديثات التجارب.

عنوان الدراسة	حالة التجربة
Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer (STAR) NCT04068753	نشط (لا يقبل مشاركين جدد)
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer NCT06878196	لم يبدأ القبول بعد
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix (BEATcc) NCT03556839	نشط (لا يقبل مشاركين جدد)
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer NCT06942416	يقبل مشاركين
The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC NCT07172217	لم يبدأ القبول بعد
Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence (MIPEX) NCT06867445	يقبل مشاركين
Spatially Fractionated Radiation Treatment for Gynaecological Cancers NCT06644846	يقبل مشاركين
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) NCT06266338	يقبل مشاركين
Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study (Retro-COSMOS) NCT06150222	لم يبدأ القبول بعد
Local Injection Methylene Blue Combined With Radiation in HNSCC Patients NCT07435415	نشط (لا يقبل مشاركين جدد)
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer NCT07418749	لم يبدأ القبول بعد
QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer NCT07186868	لم يبدأ القبول بعد
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer NCT07363330	لم يبدأ القبول بعد
Dostarlimab and Cobolimab in Advanced Cervical Cancer NCT06238635	نشط (لا يقبل مشاركين جدد)
RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer NCT06063018	يقبل مشاركين
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer NCT07472153	يقبل مشاركين
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer NCT03614949	نشط (لا يقبل مشاركين جدد)
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer NCT06455046	يقبل مشاركين
A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer NCT07424664	لم يبدأ القبول بعد
A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB (RWS-MTB) NCT06781151	يقبل مشاركين
Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy (RETRACE) NCT06771193	يقبل مشاركين
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer NCT07256236	لم يبدأ القبول بعد
SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer NCT07230626	لم يبدأ القبول بعد
A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer NCT07143292	لم يبدأ القبول بعد
Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer NCT06039891	لم يبدأ القبول بعد
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer NCT05817214	يقبل مشاركين
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix NCT05063916	نشط (لا يقبل مشاركين جدد)
A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer NCT07266350	لم يبدأ القبول بعد
AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer NCT06062589	لم يبدأ القبول بعد
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors NCT05824494	لم يبدأ القبول بعد
Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer NCT03340376	نشط (لا يقبل مشاركين جدد)
QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy NCT07141186	لم يبدأ القبول بعد
A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer (COMICE) NCT04487587	نشط (لا يقبل مشاركين جدد)
Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer NCT04906993	نشط (لا يقبل مشاركين جدد)
PRGN-2009 بالاشتراك مع بيمبروليزوماب مقابل بيمبروليزوماب لدى المرضى المصابين بسرطان عنق الرحم المتكرر أو النقيلي NCT06157151	يقبل مشاركين
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer NCT05838521	يقبل مشاركين
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer NCT06952660	يقبل مشاركين
Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer NCT07177716	لم يبدأ القبول بعد
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer NCT06459687	يقبل مشاركين
Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV NCT06456112	لم يبدأ القبول بعد
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer NCT06455072	يقبل مشاركين
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer NCT06859775	يقبل مشاركين
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer NCT06692166	يقبل مشاركين
A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer NCT07051486	يقبل مشاركين
A Study of RC48-ADC Combination With Zimberelimab Injection Therapies at Least First-line Platinum-containing Standard Therapy Failed With Recurrent or Metastatic Cervical Cancer NCT06155396	يقبل مشاركين
A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer NCT06155422	لم يبدأ القبول بعد
Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer NCT07382505	لم يبدأ القبول بعد
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies NCT05990803	يقبل مشاركين
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer NCT04982237	نشط (لا يقبل مشاركين جدد)
Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers (CoHIPP) NCT01051895	نشط (لا يقبل مشاركين جدد)

المرحلة

النوع

نوع الدراسة

الفئة العمرية

الجنس

دواء وهمي

المرحلة

النوع

نوع الدراسة

الفئة العمرية

الجنس